{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:12:36Z","timestamp":1757704356952,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10006-020-00909-9","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T13:03:26Z","timestamp":1600952606000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Apical surgery in cancer patients receiving high-dose antiresorptive medication\u2014a retrospective clinical study with a mean follow-up of 13 months"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-2895","authenticated-orcid":false,"given":"Sanne","family":"Werner Moeller Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Storgaard Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schiodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"909_CR1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.joen.2014.01.035","volume":"40","author":"F Alsalleeh","year":"2014","unstructured":"Alsalleeh F, Keippel J, Adams L, Bavitz B (2014) Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report. J Endod 40:1505\u20131507. https:\/\/doi.org\/10.1016\/j.joen.2014.01.035","journal-title":"J Endod"},{"key":"909_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schiodt M, Mendes RA et al (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127:117\u2013135. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"909_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.joen.2012.11.044","volume":"39","author":"I Tsesis","year":"2013","unstructured":"Tsesis I, Rosen E, Taschieri S, Telishevsky Strauss Y, Ceresoli V, del Fabbro M (2013) Outcomes of surgical endodontic treatment performed by a modern technique: an updated meta-analysis of the literature. J Endod 39:332\u2013339. https:\/\/doi.org\/10.1016\/j.joen.2012.11.044","journal-title":"J Endod"},{"key":"909_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.joen.2018.12.015","volume":"45","author":"T von Arx","year":"2019","unstructured":"von Arx T, Jensen SS, Janner SFM, H\u00e4nni S, Bornstein MM (2019) A 10-year follow-up study of 119 teeth treated with apical surgery and root-end filling with mineral trioxide aggregate. J Endod 45:394\u2013401. https:\/\/doi.org\/10.1016\/j.joen.2018.12.015","journal-title":"J Endod"},{"key":"909_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sdentj.2010.10.004","volume":"23","author":"T von Arx","year":"2011","unstructured":"von Arx T (2011) Apical surgery: a review of current techniques and outcome. Saudi Dent J 23:9\u201315. https:\/\/doi.org\/10.1016\/j.sdentj.2010.10.004","journal-title":"Saudi Dent J"},{"key":"909_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575. https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"key":"909_CR7","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/jco.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356\u20135362. https:\/\/doi.org\/10.1200\/jco.2009.21.9584","journal-title":"J Clin Oncol"},{"key":"909_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/iej.12018","volume":"46","author":"AT Moinzadeh","year":"2013","unstructured":"Moinzadeh AT, Shemesh H, Neirynck NA et al (2013) Bisphosphonates and their clinical implications in endodontic therapy. Int Endod J 46:391\u2013398. https:\/\/doi.org\/10.1111\/iej.12018","journal-title":"Int Endod J"},{"key":"909_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.14219\/jada.archive.2013.0134","volume":"144","author":"CA Migliorati","year":"2013","unstructured":"Migliorati CA, Saunders D, Conlon MS et al (2013) Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction. J Am Dent Assoc 144:406\u2013414. https:\/\/doi.org\/10.14219\/jada.archive.2013.0134","journal-title":"J Am Dent Assoc"},{"key":"909_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Troltzsch M, Jambrovic V et al (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg 43:847\u2013854. https:\/\/doi.org\/10.1016\/j.jcms.2015.03.039","journal-title":"J Craniomaxillofac Surg"},{"key":"909_CR11","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1016\/j.oooo.2012.08.442","volume":"117","author":"MJ Heufelder","year":"2014","unstructured":"Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 117:e429\u2013e435. https:\/\/doi.org\/10.1016\/j.oooo.2012.08.442","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"909_CR12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00520-017-4003-2","volume":"26","author":"M Schiodt","year":"2018","unstructured":"Schiodt M, Vadhan-Raj S, Chambers MS, Nicolatou-Galitis O, Politis C, Coropciuc R, Fedele S, Jandial D, Zhang J, Ma H, Saunders DP (2018) A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support Care Cancer 26:1905\u20131915. https:\/\/doi.org\/10.1007\/s00520-017-4003-2","journal-title":"Support Care Cancer"},{"key":"909_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1365-2591.2006.01180.x","volume":"39","author":"Endodontology ES of","year":"2006","unstructured":"Endodontology ES of (2006) Quality guidelines for endodontic treatment: consensus report of the European Society of Endodontology. Int Endod J 39:921\u2013930. https:\/\/doi.org\/10.1111\/j.1365-2591.2006.01180.x","journal-title":"Int Endod J"},{"key":"909_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0300-9785(72)80013-9","volume":"1","author":"J Rud","year":"1972","unstructured":"Rud J, Andreasen JO, Jensen JE (1972) Radiographic criteria for the assessment of healing after endodontic surgery. Int J Oral Surg 1:195\u2013214","journal-title":"Int J Oral Surg"},{"key":"909_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/s0901-5027(87)80080-2","volume":"16","author":"O Molven","year":"1987","unstructured":"Molven O, Halse A, Grung B (1987) Observer strategy and the radiographic classification of healing after endodontic surgery. Int J Oral Maxillofac Surg 16:432\u2013439. https:\/\/doi.org\/10.1016\/s0901-5027(87)80080-2","journal-title":"Int J Oral Maxillofac Surg"},{"key":"909_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","volume":"120","author":"O Nicolatou-Galitis","year":"2015","unstructured":"Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C (2015) Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 120:699\u2013706. https:\/\/doi.org\/10.1016\/j.oooo.2015.08.007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"909_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733\u2013759. https:\/\/doi.org\/10.1007\/s00198-007-0540-8","journal-title":"Osteoporos Int"},{"key":"909_CR18","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1158\/1078-0432.Ccr-15-3086","volume":"22","author":"A Lipton","year":"2016","unstructured":"Lipton A, Smith MR, Fizazi K, Stopeck AT, Henry D, Brown JE, Shore ND, Saad F, Spencer A, Zhu L, Warner DJ (2016) Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents. Clin Cancer Res 22:5713\u20135721. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-3086","journal-title":"Clin Cancer Res"},{"key":"909_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433\u2013441. https:\/\/doi.org\/10.1016\/j.tripleo.2006.06.004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"909_CR20","unstructured":"Robert E, Marx D (2007) Oral & intravenous bisphosphonate-induced osteonecrosis of the jaws. History, Etiology, Prevention, and Treatment. Quintessence Publishing CO, Inc"},{"key":"909_CR21","first-page":"33","volume":"61","author":"DD Damm","year":"2013","unstructured":"Damm DD, Jones DM (2013) Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays. Gen Dent 61:33\u201338","journal-title":"Gen Dent"},{"key":"909_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.coms.2014.01.009","volume":"26","author":"A Eid","year":"2014","unstructured":"Eid A, Atlas J (2014) The role of bisphosphonates in medical oncology and their association with jaw bone necrosis. Oral Maxillofac Surg Clin North Am 26:231\u2013237. https:\/\/doi.org\/10.1016\/j.coms.2014.01.009","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"909_CR23","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"909_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/07853899708998743","volume":"29","author":"HA Fleisch","year":"1997","unstructured":"Fleisch HA (1997) Bisphosphonates: preclinical aspects and use in osteoporosis. Ann Med 29:55\u201362. https:\/\/doi.org\/10.3109\/07853899708998743","journal-title":"Ann Med"},{"key":"909_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5125\/jkaoms.2014.40.5.206","volume":"40","author":"YH Kim","year":"2014","unstructured":"Kim YH, Lee HK, Song SI, Lee JK (2014) Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw. J Korean Assoc Oral Maxillofac Surg 40:206\u2013210. https:\/\/doi.org\/10.5125\/jkaoms.2014.40.5.206","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"909_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","volume":"73","author":"AM Hinson","year":"2015","unstructured":"Hinson AM, Siegel ER, Stack BC Jr (2015) Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis. J Oral Maxillofac Surg 73:53\u201362. https:\/\/doi.org\/10.1016\/j.joms.2014.07.012","journal-title":"J Oral Maxillofac Surg"},{"key":"909_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","volume":"38","author":"S Hayashida","year":"2020","unstructured":"Hayashida S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Kondo E, Kurita H, Umeda M (2020) Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. J Bone Miner Metab 38:126\u2013134. https:\/\/doi.org\/10.1007\/s00774-019-01035-7","journal-title":"J Bone Miner Metab"},{"key":"909_CR28","doi-asserted-by":"publisher","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","volume":"6","author":"C Ottesen","year":"2020","unstructured":"Ottesen C, Schiodt M, Gotfredsen K (2020) Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon 6:e03795. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","journal-title":"Heliyon"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00909-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-020-00909-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00909-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T07:37:31Z","timestamp":1632469051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-020-00909-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s10006-020-00909-9","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"type":"print","value":"1865-1550"},{"type":"electronic","value":"1865-1569"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Morten Schiodt was a consultant for Amgen and had received research support from Amgen. He had no conflict of interest. The other authors have no commercial associations or dual commitments that might create a conflict of interest in connection with the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients were fully informed about treatment alternatives and the surgical procedure according to the Declaration of Helsinki (1963) and its later amendments. The regional scientific ethical committee provided a document exemption and the local data protection agency approved handling of the recorded data (No. 2012-41-0045).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of informed consent"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs. , , and .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}